MedPath

survey of preventive effect of magnesium sulphate on postoperative pain of pregnant women undergoing Cesarian sectio

Not Applicable
Conditions
pregnancy.
Other specified complications of labour and delivery
Registration Number
IRCT201212245225N3
Lead Sponsor
Tehran university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
50
Inclusion Criteria

inclusion criteria: pregnant women with ASA I,II (American Society of Anesthesiologists) scheduled for elective Cesarian section under general anesthesia

exclusion criteria: hypermagnesemia, insufficient time for giving study drugs,sensitivity to magnesium sulphate, heart blocks,hypertension,diabetes,renal disease, cardiovascular disease,history of analgesic intake during the past 24 hours,fetal distress, multiparity

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of postoperative pain. Timepoint: 1st, 6th,12th,24th hours after cesarian section. Method of measurement: short MCGillL pain questionaire.
Secondary Outcome Measures
NameTimeMethod
Hemodynamic changes( blood pressure and heart rate). Timepoint: at induction and tracheal intubation and during surgical procedure and in recovery period. Method of measurement: by means of a mercury manometre and a cardiac monitor.;Analgesic requirements. Timepoint: during 24 hours after completion of cesarian section. Method of measurement: by means of recorded amounts of infused analgesic which displayed on a PCA pomp.
© Copyright 2025. All Rights Reserved by MedPath